IP Library › Granted Patent US 7,553,829
Granted Patent B2
US 7,553,829 · App. 10/433,043 · Granted Jun 30, 2009

Treatment of chronic fatigue syndrome and fibromyalgia syndrome

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,829
App. No.
10/433,043
Granted
Jun 30, 2009
Kind
B2
Abstract

Chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS) can be treated by the administration of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof.

Claims (7)

1. A method of treating chronic fatigue syndrome comprising administering a therapeutically effective amount of a compound to a mammal in need of such treatment wherein the compound is selected from Δ5-androstene-3β-ol-7,17 dione, Δ5-androstene-3β, 17β-diol-7-one, Δ5-androstene-3β, 7α-diol-17-one, Δ5-androstene-3β, 7β-diol-17-one and the corresponding acetyl esters of these steroids.

2. The method of claim 1 wherein the subject is a mammal.

3. The method of claim 2 wherein the subject is a dog or a cat.

4. The method of claim 2 wherein the subject is a human.

5. The method of claim 1 wherein the compound is administered orally.

6. The method of claim 1 wherein the compound is Δ5-androstene-3β-acetoxy-7,17 dione.

7. The method of claim 1 wherein the compound is administered daily.

Assignments (16)
CHANGE OF NAME Recorded Oct 15, 2021
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: LONZA CONSUMER HEALTH INC.
Reel/Frame 057828/0594 →
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2016
From: MADISON CAPITAL FUNDING LLC
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040234/0538 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Sep 12, 2016
From: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040068/0687 →
RELEASE AND REASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY INTERESTS Recorded Aug 23, 2016
From: UNICREDIT BANK AG, NEW YORK BRANCH AS SECURED PARTY IN POSSESSION OF THE ASSETS OF HILCO FINANCIAL LLC
To: HUMANETICS CORPORATION; ADVANTRX CORPORATION
Reel/Frame 039784/0922 →
SECURITY INTEREST Recorded Apr 23, 2015
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 035486/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2014
From: HUMANETICS CORPORATION
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 033645/0212 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033293/0475 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033300/0527 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2014
From: WHITEBOX ADVISORS, LLC
To: HUMANETICS CORPORATION
Reel/Frame 033289/0553 →
ASSIGNMENT OF PATENT SECURITY AGREEMENT RECORDED 04/05/07 WITH USPTO AT REEL 019116, FRAME 0641 Recorded Jan 27, 2012
From: UNICREDIT BANK AG, NEW YORK BRANCH, AS ATTORNEY-IN-FACT FOR HILCO FINANCIAL, LLC (N/K/A 1310 FINANCIAL, LLC) UNDER POA DATED DECEMBER 24, 2008
To: UNICREDIT BANK AG, NEW YORK BRANCH
Reel/Frame 027612/0709 →
SECURITY AGREEMENT Recorded Dec 4, 2009
From: HUMANETICS CORPORATION
To: HOPFENSPIRGER, LARRY
Reel/Frame 023594/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2007
From: ZENK, RONALD J.; ZENK, JOHN L.
To: HUMANETICS CORPORATION
Reel/Frame 019954/0885 →
SECURITY AGREEMENT Recorded Apr 5, 2007
From: HUMANETICS CORPORATION
To: HILCO FINANCIAL, LLC
Reel/Frame 019116/0641 →
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2007
From: DENT, AS COLLATERAL AGENT, DAVID
To: HUMANETICS CORPORATION
Reel/Frame 018866/0549 →
SECURITY AGREEMENT Recorded Feb 14, 2006
From: HUMANETICS CORPORATION
To: WHITEBOX ADVISORS, LLC, AS COLLATERAL AGENT
Reel/Frame 017164/0276 →
SECURITY INTEREST Recorded Oct 27, 2003
From: HUMANETICS CORPORATION
To: DAVID DENT, AS COLLATERIAL AGENT
Reel/Frame 015478/0430 →